(British Society of Gastroenterology)
- Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
- Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohns disease: post hoc analysis of the RISK study
- Exploring the role of genetics, gut microbiota and blood metabolites in IBD
- Perplexing case of abdominal pain with eosinophilia and fasciitis
- Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
- Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway
- Novel mouse model for studying transmural intestinal fibrosis and creeping fat formation in stricturing Crohns disease
- Variceal band ligation and carvedilol: together forever, or not?
- Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma
- Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
- Rethinking routine mapping biopsies in gastric intestinal metaplasia: justification for endoscopic stratification
- Environmental and healthcare trade-offs between single-use and reusable gastroscopes
- Aspirin is associated with lower risk of pancreatic cancer and cancer-related mortality in patients with diabetes mellitus
- Unravelling lipidomic disruptions across multiple tissues in Chd8-mutant ASD mice through integration of lipidomics and single-cell transcriptomics
- Cold EMR, hot EMR or ESD for large benign adenoma: not one size fits all
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
